Toronto, Ontario–(Newsfile Corp. – October 19, 2021) – Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the “Company” or “Psyched“) a life sciences company focused on the production and distribution of artisanal functional and psychedelic mushrooms, is pleased to announce the preliminary data revealing a potential new functional property and health benefit of AME-1.

Source

Previous articlePT267 – Rebecca Kronman, LCSW – Psychedelics, Pregnancy, and Parenthood
Next articlePharmaTher Engages Alcami for Clinical and Commercial Manufacturing of Novel Ketamine Products